New cholesterol drug shows promise in major trial
NCT ID NCT03540355
Summary
This study tested whether a medication called Cipros 20 could safely lower bad cholesterol (LDL) and triglycerides in adults with high cardiovascular risk. It involved 406 participants in Brazil who were randomly assigned to receive either the study drug or a comparison treatment. The main goal was to see how well it reduced blood fat levels and to monitor for any side effects.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DYSLIPIDEMIAS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Allergisa
Campinas, São Paulo, Brazil
Conditions
Explore the condition pages connected to this study.